Stay updated on Amivantamab in Adenoid Cystic Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.

Latest updates to the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page
- ChecktodayNo Change Detected
 - Check7 days agoChange DetectedThe updates appear to be minor formatting adjustments with no changes to essential study details or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

 - Check29 days agoChange Detected- Removed reference to Adrenal cortex carcinoma and version v3.1.0. - Added notice about funding lapse and current NIH Clinical Center status, a new term Adenoid cystic carcinoma, and a new revision version v3.2.0.SummaryDifference3%

 - Check36 days agoChange DetectedUpdate: version tag upgraded from v3.0.2 to v3.1.0, replacing the old revision with a new one. No other content changes detected.SummaryDifference0.1%

 - Check50 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2; the 'Back to Top' link/text was removed.SummaryDifference0.2%

 - Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%

 - Check65 days agoChange DetectedThe web page has updated its facility name and location details, specifically adding 'St Louis, Missouri, United States, 63130' and 'amivantamab', while removing references to 'Saint Louis, Missouri, United States, 63130' and 'Amivantamab-vmjw'.SummaryDifference3%

 
Stay in the know with updates to Amivantamab in Adenoid Cystic Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.